Works matching IS 09147187 AND DT 2022 AND VI 36 AND IP 3

Results: 14

Optimization of FDG PET study after mRNA COVID-19 vaccination to reduce the interference of vaccine-associated hypermetabolic lymphadenopathy.

Published in:

2022

By:

Thaweerat, Wajana

Publication type:

Letter

Correction to: Serial change in perfusion–metabolism mismatch after coronary artery bypass grafting.

Published in:

2022

By:

Morishima, Motoko;
Kiriyama, Tomonari;
Miyagi, Yasuo;
Otsuka, Toshiaki;
Fukushima, Yoshimitsu;
Kumita, Shin-ichiro;
Ishii, Yosuke

Publication type:

Correction Notice

Development of a novel Indium-111 radiolabeled mogamulizumab targeting CCR4 for imaging adult T-cell leukemia/lymphoma in vivo.

Published in:

Annals of Nuclear Medicine, 2022, v. 36, n. 3, p. 319, doi. 10.1007/s12149-021-01706-4

By:

Shimizu, Yoichi;
Koyasu, Sho;
Suzukida, Mari;
Izumi, Kiyotaka;
Kidera, Eitaro;
Shindo, Takero;
Saga, Tsuneo;
Ono, Masahiro;
Takaori-Kondo, Akifumi;
Nakamoto, Yuji

Publication type:

Article

Dual time point imaging of staging PSMA PET/CT quantification; spread and radiomic analyses.

Published in:

2022

By:

Aksu, Ayşegül;
Vural Topuz, Özge;
Yılmaz, Gülşah;
Çapa Kaya, Gamze;
Yılmaz, Burçak

Publication type:

journal article

Detection efficacy of PET/CT with 18F-FSU-880 in patients with suspected recurrent prostate cancer: a prospective single-center study.

Published in:

Annals of Nuclear Medicine, 2022, v. 36, n. 3, p. 302, doi. 10.1007/s12149-021-01704-6

By:

Otani, Tomoaki;
Saga, Tsuneo;
Ishimori, Takayoshi;
Kidera, Eitaro;
Shimizu, Yoichi;
Aizawa, Rihito;
Nakamura, Kiyonao;
Goto, Takayuki;
Akamatsu, Shusuke;
Mizowaki, Takashi;
Nakamoto, Yuji

Publication type:

Article

Prostate-specific membrane antigen and fibroblast activation protein distribution in prostate cancer: preliminary data on immunohistochemistry and PET imaging.

Published in:

Annals of Nuclear Medicine, 2022, v. 36, n. 3, p. 293, doi. 10.1007/s12149-021-01702-8

By:

Kessel, Katharina;
Seifert, Robert;
Weckesser, Matthias;
Boegemann, Martin;
Huss, Sebastian;
Kratochwil, Clemens;
Haberkorn, Uwe;
Giesel, Frederik;
Rahbar, Kambiz

Publication type:

Article

A design of forceps-type coincidence radiation detector for intraoperative LN diagnosis: clinical impact estimated from LNs data of 20 esophageal cancer patients.

Published in:

2022

By:

Takahashi, Miwako;
Yoshimura, Shuntaro;
Takyu, Sodai;
Aikou, Susumu;
Okumura, Yasuhiro;
Yagi, Koichi;
Fukayama, Masashi;
Momose, Toshimitsu;
Seto, Yasuyuki;
Yamaya, Taiga

Publication type:

journal article

Validity of the γ-Ray Evaluation with iodoamphetamine for Cerebral Blood Flow Assessment (REICA) method for quantification of cerebral blood flow including acetazolamide challenge test.

Published in:

2022

By:

Miyazaki, Yoshiaki;
Kameyama, Masashi;
Nakamizo, Akira;
Noguchi, Tomoyuki;
Tabata, Nobuyuki

Publication type:

journal article

An open-label, single-arm, multi-center, phase II clinical trial of single-dose [131I]meta-iodobenzylguanidine therapy for patients with refractory pheochromocytoma and paraganglioma.

Published in:

Annals of Nuclear Medicine, 2022, v. 36, n. 3, p. 267, doi. 10.1007/s12149-021-01699-0

By:

Inaki, Anri;
Shiga, Tohru;
Tsushima, Yoshito;
Jinguji, Megumi;
Wakabayashi, Hiroshi;
Kayano, Daiki;
Akatani, Norihito;
Yamase, Takafumi;
Kunita, Yuji;
Watanabe, Satoru;
Hiromasa, Tomo;
Mori, Hiroshi;
Hirata, Kenji;
Watanabe, Shiro;
Higuchi, Tetsuya;
Tomonaga, Hiroyasu;
Kinuya, Seigo

Publication type:

Article

Tumor glycolytic heterogeneity improves detection of regional nodal metastasis in patients with lung adenocarcinoma.

Published in:

Annals of Nuclear Medicine, 2022, v. 36, n. 3, p. 256, doi. 10.1007/s12149-021-01698-1

By:

Lue, Kun-Han;
Chu, Sung-Chao;
Wang, Ling-Yi;
Chen, Yen-Chang;
Li, Ming-Hsun;
Chang, Bee-Song;
Chan, Sheng-Chieh;
Chen, Yu-Hung;
Lin, Chih-Bin;
Liu, Shu-Hsin

Publication type:

Article

Serial change in perfusion–metabolism mismatch after coronary artery bypass grafting.

Published in:

Annals of Nuclear Medicine, 2022, v. 36, n. 3, p. 244, doi. 10.1007/s12149-021-01696-3

By:

Morishima, Motoko;
Kiriyama, Tomonari;
Miyagi, Yasuo;
Otsuka, Toshiaki;
Fukushima, Yoshimitsu;
Kumita, Shin-ichiro;
Ishii, Yosuke

Publication type:

Article

Feasibility of 125I-RGD uptake as a marker of angiogenesis after myocardial infarction.

Published in:

Annals of Nuclear Medicine, 2022, v. 36, n. 3, p. 235, doi. 10.1007/s12149-021-01695-4

By:

Yamase, Takafumi;
Taki, Junichi;
Wakabayashi, Hiroshi;
Inaki, Anri;
Hiromasa, Tomo;
Mori, Hiroshi;
Akatani, Norihito;
Ogawa, Kazuma;
Shiba, Kazuhiro;
Kinuya, Seigo

Publication type:

Article

Prognostic value of total tumour volume, adding necrosis to metabolic tumour volume, in advanced or metastatic non-small cell lung cancer treated with first-line pembrolizumab.

Published in:

Annals of Nuclear Medicine, 2022, v. 36, n. 3, p. 224, doi. 10.1007/s12149-021-01694-5

By:

Eude, Florian;
Guisier, Florian;
Salaün, Mathieu;
Thiberville, Luc;
Pressat-Laffouilhere, Thibault;
Vera, Pierre;
Decazes, Pierre

Publication type:

Article

I-124 PET/CT image-based dosimetry in patients with differentiated thyroid cancer treated with I-131: correlation of patient-specific lesional dosimetry to treatment response.

Published in:

2022

By:

Plyku, Donika;
Hobbs, Robert F.;
Wu, Di;
Garcia, Carlos;
Sgouros, George;
Van Nostrand, Douglas

Publication type:

journal article

Works matching IS 09147187 AND DT 2022 AND VI 36 AND IP 3

Optimization of FDG PET study after mRNA COVID-19 vaccination to reduce the interference of vaccine-associated hypermetabolic lymphadenopathy.

Correction to: Serial change in perfusion–metabolism mismatch after coronary artery bypass grafting.

Development of a novel Indium-111 radiolabeled mogamulizumab targeting CCR4 for imaging adult T-cell leukemia/lymphoma in vivo.

Dual time point imaging of staging PSMA PET/CT quantification; spread and radiomic analyses.

Detection efficacy of PET/CT with <sup>18</sup>F-FSU-880 in patients with suspected recurrent prostate cancer: a prospective single-center study.

Prostate-specific membrane antigen and fibroblast activation protein distribution in prostate cancer: preliminary data on immunohistochemistry and PET imaging.

A design of forceps-type coincidence radiation detector for intraoperative LN diagnosis: clinical impact estimated from LNs data of 20 esophageal cancer patients.

Validity of the γ-Ray Evaluation with iodoamphetamine for Cerebral Blood Flow Assessment (REICA) method for quantification of cerebral blood flow including acetazolamide challenge test.

An open-label, single-arm, multi-center, phase II clinical trial of single-dose [<sup>131</sup>I]meta-iodobenzylguanidine therapy for patients with refractory pheochromocytoma and paraganglioma.

Tumor glycolytic heterogeneity improves detection of regional nodal metastasis in patients with lung adenocarcinoma.

Serial change in perfusion–metabolism mismatch after coronary artery bypass grafting.

Feasibility of <sup>125</sup>I-RGD uptake as a marker of angiogenesis after myocardial infarction.

Prognostic value of total tumour volume, adding necrosis to metabolic tumour volume, in advanced or metastatic non-small cell lung cancer treated with first-line pembrolizumab.

I-124 PET/CT image-based dosimetry in patients with differentiated thyroid cancer treated with I-131: correlation of patient-specific lesional dosimetry to treatment response.